We hope that the peptide drug developed in this study could be a viable option for second-line adjuvant tumor therapy
This article does not assert that the four components produce additive, synergistic, or otherwise interacting effects when combined in any model system
Fox Foundation Trial Finder, 43 the Washington PD Registry, 44 ClinicalTrials.gov (NCT02324426), and referral from local health-care providers
But theres another antioxidant that deserves your attention glutathione
These are observations from preclinical models (rodents) not an effect confirmed in humans, but a research direction on the systemic regulation observed for the peptide
Others, called generalized nootropics, are less focused